| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |